Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Nov 27;1(1):39.
doi: 10.1186/2047-2994-1-39.

The Gut Is the Epicentre of Antibiotic Resistance

Affiliations
Free PMC article
Editorial

The Gut Is the Epicentre of Antibiotic Resistance

Jean Carlet. Antimicrob Resist Infect Control. .
Free PMC article

Abstract

The gut contains very large numbers of bacteria. Changes in the composition of the gut flora, due in particular to antibiotics, can happen silently, leading to the selection of highly resistant bacteria and Candida species. These resistant organisms may remain for months in the gut of the carrier without causing any symptoms or translocate through the gut epithelium, induce healthcare-associated infections, undergo cross-transmission to other individuals, and cause limited outbreaks. Techniques are available to prevent, detect, and treat the carriage of resistant organisms in the gut. However, evidence on these techniques is scant, the only exception being selective digestive decontamination (SDD), which has been extensively studied in neutropenic and ICU patients. After the destruction of resistant colonizing bacteria, which has been successfully obtained in several studies, the gut could be re-colonized with normal faecal flora or probiotics. Studies are warranted to evaluate this concept.

Similar articles

See all similar articles

Cited by 39 articles

See all "Cited by" articles

References

    1. Carlet J, Collignon P, Goldmann P. et al. Society’s failure to protect a precious resource: antibiotics. Lancet. 2011;378:369–371. doi: 10.1016/S0140-6736(11)60401-7. - DOI - PubMed
    1. Hughes JM. Preserving the lifesaving power of antimicrobial agents. Jama. 2011;305:1027–1028. doi: 10.1001/jama.2011.279. - DOI - PubMed
    1. Piddock LJ. The crisis of no new antibiotics-what is the way forward. Lancet Infect Dis. 2012;12:24953. - PubMed
    1. Bush K, Courvalin P, Gautam D. et al. Tackling antibiotic resistance. Nature reviews/microbiology. 2011;9:894–895. doi: 10.1038/nrmicro2693. - DOI - PMC - PubMed
    1. Lowe CF, McGeer A, Muller MP, Katz K. for the Toronto ESBL working group. Decreased susceptibility to non-carbapenem antimicrobials in extended-spectrum-B-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada. Antimicrob Agents Chemother. 2012;56:3977–3980. doi: 10.1128/AAC.00260-12. - DOI - PMC - PubMed

Publication types

LinkOut - more resources

Feedback